References
1. Brachman
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1522900/
2. The Department of Defense Anthrax Vaccine Immunization Program: Unproven Force Protection Fourth Report by the Committee on Government Reform
https://www.govinfo.gov/content/pkg/CRPT-106hrpt556/html/CRPT-106hrpt556.htm
3. Research Advisory Committee on Gulf War Veterans' Illnesses Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations Washington, D.C.: U.S. Government Printing Office, November 2008
https://www.va.gov/RAC-GWVI/docs/Committee_Documents/GWIandHealthofGWVeterans_RAC-GWVIReport_2008.pdf
4. Clarifying Guidance for the Smallpox and Anthrax Vaccination Programs
https://www.centcom.mil/AREA-OF-RESPONSIBILITY/
5. VAERS database
https://vaers.hhs.gov/
6. What is a Serious Adverse Event?
https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event
7. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Rosenthal S1, Chen R. 1995.
http://www.ncbi.nlm.nih.gov/pubmed/7503351
8. Electronic Support for Public Health-Vaccine Adverse Event Reporting System
https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
9. Is the US's Vaccine Adverse Event Reporting System broken?
https://www.bmj.com/content/383/bmj.p2582
10. Clinical Policy for the Administration of Anthrax Vaccine Adsorbed July 31st 2009
https://health.mil/Reference-Center/Policies/2009/07/31/Clinical-Policy-for-the-Administration-of-the-Anthrax-Vaccine-Adsorbed
11. U.S. General Accounting Office. Anthrax Vaccine: GAO's Survey of Guard and Reserve Pilots and Aircrew. Washington, D.C. Sep, 2002.
https://www.gao.gov/assets/gao-02-445.pdf
12. The Anthrax Vaccine: Is It Safe? Does It Work? (2002)
https://nap.nationalacademies.org/catalog/10310/the-anthrax-vaccine-is-it-safe-does-it-work
13. Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines
http://iom.nationalacademies.org/Reports/2000/Gulf-War-and-Health-Vol-1-Depleted-Uranium-Sarin-Pyridostigmine-Bromide-and-Vaccines.aspx
14. DoD Faces Challenges in implementing its Anthrax Vaccine Immunisation Program
https://www.gao.gov/products/NSIAD-00-36
15. GAO: Military Health: DOD's Vaccine Healthcare Centers Network 29th June 2007.
http://www.gao.gov/new.items/d07787r.pdf
16. https://www.health.mil/Military-Health-Topics/Health-Readiness/AFHSD/Data-Management-and-Technical-Support/Defense-Medical-Surveillance-System
17. The Defense Medical Surveillance System and the Department of Defense Serum Repository: Glimpses of the Future of Public Health Surveillance Rubertone M 2002
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447349/
18. U.S. Barred From Forcing Troops to Get Anthrax Shots
https://www.washingtonpost.com/archive/politics/2004/10/28/us-barred-from-forcing-troops-to-get-anthrax-shots/563b1195-3fdd-475c-808f-53428137bfc8/
19. US soldiers refuse to fall in line with anthrax vaccination scheme
https://www.nature.com/articles/nm0204-112b
20. Comprehensive systematic surveillance for adverse effects of Anthrax Vaccine Adsorbed, US Armed Forces, 1998–2000Jeffrey L. Lange et al. 2003
https://pubmed.ncbi.nlm.nih.gov/12639483/
21. CDC Anthrax Vaccine Safety and Efficacy Research program
https://www.nap.edu/read/10527/chapter/1
22. Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed. Payne et al. 2007.
http://www.ncbi.nlm.nih.gov/pubmed/16444796
23. Detailed Safety Review of Anthrax Vaccine Adsorbed January 2015 Compiled by the Immunization Healthcare Branch Defense Health Agency, Falls Church, Virginia
https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Anthrax/Anthrax-Resource-Center
24. Risk of disability for US army personnel vaccinated against anthrax, 1998-2005.
Sulsky et al. 2011
https://www.ncbi.nlm.nih.gov/pubmed/21704102
25. Disability among US Army Veterans vaccinated against anthrax. Sulsky et al. 2012.
https://www.ncbi.nlm.nih.gov/pubmed/22874851/
26. Package insert
https://www.fda.gov/media/71954/download
27. https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Anthrax
28. Getting Rich on Uncle Sucker Should the Federal Government Strengthen Efforts to Fight Profiteering? Scott Lilly October 2010
https://www.americanprogress.org/wp-content/uploads/issues/2010/10/pdf/unclesucker_execsumm.pdf
29. Company Led by Top Admiral Buys Michigan Vaccine Lab
https://www.nytimes.com/1998/07/08/us/company-led-by-top-admiral-buys-michigan-vaccine-lab.html
30. Emergent Biosolutions / Bioport Board of Directors: How to Sell to the US Government. Nass, M
http://anthraxvaccine.blogspot.com/2007/06/emergent-biosolutionsbioport-board-of.html
31. Emergent Biosolutions Awarded BARDA Contract for Advanced Development and Delivery of Nuthrax a Next Generation Antrhax Vaccine, Valued at up to $1.6 Billion.
https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-awarded-barda-contract-advanced
32. Data show a difference in incidence of local reactions between lots of Anthrax vaccine: short-term safety experience in humans Pittman P 2001
https://pubmed.ncbi.nlm.nih.gov/11738765/
33. Encl. 18: Microscopy video, pin prick blood from Th1 chronically ill patients.
http://www.autoimmunityresearch.org/lax2006.ram
34. Bacterial persistence and expression of disease. Domingue et al. 1997.
https://www.ncbi.nlm.nih.gov/pubmed/9105757
35. Demystifying pleomorphic forms in persistence and expression of disease: Are they bacteria, and is peptidoglycan the solution? Domingue. 2010
https://www.ncbi.nlm.nih.gov/pubmed/20875345
36. Cell Wall-deficient Bacteria as a Cause of Infections: a Review of the Clinical Significance. Onwuamaegbu et el. 2005.
https://www.ncbi.nlm.nih.gov/pubmed/15651712
37. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes. Proal et al. 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28245427
38. New insights into bacterial persistence in reactive arthritis. Astraukiene et al. 2007.
https://www.ncbi.nlm.nih.gov/pubmed/17631749
39. L-form bacteria cohabitants in human blood: significance for health and diseases.
Markova. 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28715646
40. Differential transcriptional response in macrophages infected with cell wall deficient versus normal Mycobacterium Tuberculosis. Fu et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25552926
41. Interaction of alveolar macrophages with Staphylococcus aureus and induction of microbial L-forms during infection in rats. Michailova et al. 2000.
https://www.ncbi.nlm.nih.gov/pubmed/10959728
42. Atypical behaviour and survival of Streptococcus pyogenes L forms during intraperitoneal infection in rats. Michailova et al. 2000.
https://www.ncbi.nlm.nih.gov/pubmed/10767608
43. Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma. Ou et al. 2014.
https://www.ncbi.nlm.nih.gov/pubmed/24589592
44. Cell-wall-deficient bacteria: a major etiological factor for psoriasis? Wang et al. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/20137493
45. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Amar et al. 2011.
https://www.ncbi.nlm.nih.gov/pubmed/2197614
46. How bacterial pathogens colonize their hosts and invade deeper tissues.
Ribet et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25637951
47. New Insights into Bacterial Persistence in Reactive Arthritis Astrauskiene et al. 2007
https://pubmed.ncbi.nlm.nih.gov/17631749/
48. The Dormant Blood Micribiome in Chronic Inflammatory Illnesses Poteieter et el. 2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487407/
49. Filterable forms and L-forms of Mycobacterium bovis BCG: impact for live vaccine features. Markova et a. 2012.
https://www.ncbi.nlm.nih.gov/pubmed/22495116
50. Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination.
Markova et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25874947
51. Inflammatory disease and the human microbiome. Proal et al. 2014.
https://www.ncbi.nlm.nih.gov/pubmed/24882717
52. Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis. Proal et al. 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23576059
53. The human microbiome and autoimmunity. Proal et al. 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23370376
54. Immunostimulation in the era of the metagenome. Proal et al. 2011.
https://www.ncbi.nlm.nih.gov/pubmed/21278764
55. Autoimmune disease in the era of the metagenome. Proal et al. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/19393196
56. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Marshall TG et al. 2006.
https://www.ncbi.nlm.nih.gov/pubmed/16403216
57. https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Recommendations/Vaccine-Recommendations-by-AOR
58. Children’s Health Defense
https://childrenshealthdefense.org/defender/welcome-to-the-defender/
59. Informed Consent Action Network
https://icandecide.org/
60. Prevalence and patterns of Gulf War Illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Steele L. 2000
https://pubmed.ncbi.nlm.nih.gov/11092441/
61. Health and exposures of United Kingdom Gulf War Veterans, II: the relation of health to exposure. Cherry N, et al. 2001
Part 1 https://oem.bmj.com/content/58/5/291
Part 2 https://oem.bmj.com/content/58/5/299
62. Health of UK servicemen who served in Persian Gulf War. Unwin C, et al. 1999.
https://pubmed.ncbi.nlm.nih.gov/9923871/
63. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. Hotoph M, et al. 2000.
https://pubmed.ncbi.nlm.nih.gov/10818024/
64. Reanalysis of Gulf War vaccination data does not contradict
findings. Hotoph M. 2000
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127872/
65. Anthrax vaccination and self-reported symptoms, functional status and medical conditions inthe national health survey of Gulf War era veterans and their families Mahan CM et al. 2004
https://pubmed.ncbi.nlm.nih.gov/15018879/
66. Increased symptom reporting was associated with several exposures, including having more than 10 immunisations, Kelsall et al. 2004
https://pubmed.ncbi.nlm.nih.gov/15550607/
67. CDC children’s vaccines
https://www.cdc.gov/vaccines/vpd/vaccines-age.html
68. 72 Vaccine Doses and No Placebo Trials
https://icandecide.org/72-vaccine-doses-no-placebo-trials/
69. Data and Statistics on Children’s Mental Health
https://www.cdc.gov/childrensmentalhealth/data.html
70. Gupta RS, Warren CM, Smith BM, Blumenstock JA, Jiang J, Davis MM, Nadeau KC. The public health impact of parent-reported childhood food allergies in the united states. Pediatrics. 2018;142(6):e20181235.
https://pubmed.ncbi.nlm.nih.gov/30455345/
71. A National and State Profile of Leading Health Problems and Health Care Quality for US Children: Key Insurance Disparities and Across-State Variations Bethell, C 2011
https://www.academicpedsjnl.net/article/S1876-2859(10)00250-0/fulltext
72. Dynamics of obesity and chronic health conditions among children and youth cleave 2010.
https://pubmed.ncbi.nlm.nih.gov/20159870/
73. Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders Hooker, B. et al.2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268563/
74. Health effects in vaccinated versus unvaccinated children, with covariates for breastfeeding status and type of birth HookerB. et al. 2021
https://www.oatext.com/pdf/JTS-7-459.pdf
75. Lyons Weiler Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination Lyons-Weiler J. et al. 2020
https://pubmed.ncbi.nlm.nih.gov/33266457/
76. Retraction: Lyons-Weiler, J.; Thomas, P. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination. Int. J. Environ. Res. Public Health 2020, 17, 8674
https://pubmed.ncbi.nlm.nih.gov/34360528/
77. Correction: Lyons-Weiler, J., et al. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination. Int. J. Environ. Res. Public Health 2020, 17, 8674 James Lyons-Weiler 1 , Paul Thomas
https://pubmed.ncbi.nlm.nih.gov/33499430/
78. Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them James Lyons-Weiler ET AL.2022
https://www.researchgate.net/publication/363882194_Revisiting_Excess_Diagnoses_of_Illnesses_and_Conditions_in_Children_Whose_Parents_Provided_Informed_Permission_to_Vaccinate_Them
79. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children Mawson A. et al. 2017
https://www.oatext.com/pdf/JTS-3-186.pdf
80. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children Anthony R Mawson 2017
https://www.oatext.com/pdf/JTS-3-187.pdf
81. The relationship between vaccination and self report of atopic disease in children Enriquez R. Et al. 2005
https://pubmed.ncbi.nlm.nih.gov/15805992/
82. Vax-Unvax: Let the Science Speak (Children’s Health Defense)
https://mitpressbookstore.mit.edu/book/9781510766969
83. Lotter V. Epidemiology of autistic conditions in young children 1966
https://link.springer.com/article/10.1007/BF00584048
84. https://www.cdc.gov/ncbddd/autism/data.html
85. Autism and Deveopmental Disabilities Monitoring Network 2023
https://www.cdc.gov/ncbddd/autism/pdf/ADDM-Community-Report-SY2020-h.pdf
86. Prevalence of Autism (including Asperger Syndrome) in School Age Children in Northern Ireland. Annual Report 2025
https://www.health-ni.gov.uk/sites/default/files/2025-05/asd-children-ni-2025.pdf
87. The proportion of minimally verbal children with autism spectrum disorder in a community-based early intervention programme. Rose V. 2016
https://pubmed.ncbi.nlm.nih.gov/27120989/
88. National Autistic Society New shocking data highlights the autism employment gap
https://www.autism.org.uk/what-we-do/news/new-data-on-the-autism-employment-gap
89. emergence of asd in simplex families: relations to parental perceptions on etiology
Goin Kochel R. 2015
https://pubmed.ncbi.nlm.nih.gov/25398603/
90. parental perceptions and use of complementary and alternative medicine practices for children with asd in private practice harrington J. 2006
https://pubmed.ncbi.nlm.nih.gov/16685182/
92. Adverse Effects of Vaccines Evidence and Causality
https://nap.nationalacademies.org/catalog/13164/adverse-effects-of-vaccines-evidence-and-causality
93. Does Vaccination Increase the Risk of Autism Spectrum Disorder? Mohammed et al. 2022.
https://pubmed.ncbi.nlm.nih.gov/36110492/
94. Vaccine Safety: Myths and Misinformation Geoghegan et al. 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090020/
95. The myth of vaccination and autism spectrum Gabis et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/34996019/
96. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies Taylor L. et al. 2014
https://pubmed.ncbi.nlm.nih.gov/24814559/
97. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults Fraiman J. et al. 2022
https://pubmed.ncbi.nlm.nih.gov/36055877/
98. FDA oversight of clinical trials is “grossly inadequate,” say experts.
https://www.bmj.com/content/379/bmj.o2628
99. React 19 group
https://react19.org/science
100. Excess deaths 2025. Campbell, J.
https://www.youtube.com/watch?v=OlBvymt5bAs
101. https://www.militaryaccountability.com/
102. Industry reduced early-stage research, favoring medical devices, bioengineered drugs, and late-stage clinical trials Moses, H. 2015
https://pubmed.ncbi.nlm.nih.gov/25585329/
103. Trial sans Error: How Pharma-Funded Research Cherry-Picks Positive Results
https://www.scientificamerican.com/article/trial-sans-error-how-pharma-funded-research-cherry-picks-positive-results/
104. The Impact of Industry Funding on Randomized Controlled Trials of Biologic Therapies Gazendam,1. et al. 2022
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951352/
105. How pharmaceutical industry funding affects trial outcomes: Causal structures and responses? Author links open overlay panel Sergio Sismondo 2008
https://www.sciencedirect.com/science/article/abs/pii/S0277953608000361
106. Cochrane Industry sponsorship and research outcome
https://www.cochrane.org/MR000033/METHOD_industry-sponsorship-and-research-outcome
107. Industry Funding of Clinical Trials: Benefit or Bias? Sameer S. Chopra, AM
https://jamanetwork.com/journals/jama/fullarticle/196846
108. Evidence-based medicine has been hijacked: a report to David Sackett 2003
https://www.jclinepi.com/article/S0895-4356%2816%2900147-5/abstract?cc=y=
://fas.org/sgp/crs/misc/R43341.pdf
109. Scientific American: How drug company money is undermining science.
https://www.scientificamerican.com/article/how-drug-company-money-undermining-science/
110. Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science Sismondo, S. 2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028448/
111. Cochrane Industry sponsorship and research outcome
https://pubmed.ncbi.nlm.nih.gov/23235689/
112. The decline of science at the FDA has become unmanageable Ross B 2023
https://www.bmj.com/content/381/bmj.p1061
113. https://vaxxedthemovie.com/stream/
114. https://www.merck.com/news/dr-julie-l-gerberding-to-retire-from-merck/
115. https://www.merck.com/news/merck-announces-appointment-of-dr-julie-gerberding-as-executive-vice-president-for-strategic-communications-global-public-policy-and-population-health/
116. Improving medical research in the United Kingdom Stephen H. Bradley, Nicholas J. DeVito, Kelly E. Lloyd, Patricia Logullo & Jessica E. Butler 2022
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-022-06050-y
117. https://www.britannica.com/biography/Ignaz-Semmelweis
118. Suppressing Scientific Discourse on Vaccines? Self-perceptions of researchers and practitioners Elisha E 2022
https://pubmed.ncbi.nlm.nih.gov/35587319/
119. Emergent BioSolutions to Support HHS Anthrax Preparedness Strategy With Up to $1 Billion in BioThrax Deliveries to the Strategic National Stockpile
120. Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
https://www.sec.gov/Archives/edgar/data/1367644/000136764423000199/a11282023cyfendus.htm
121. Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
122. Statistica
https://www.statista.com/topics/1719/pharmaceutical-industry/#topicOverview
123. Possible role of L-form switching in recurrent urinary tract infection. Mickiewicz et al. 2019
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763468/
124. Repurposing Drugs with Specific Activity Against L-Form Bacteria. Emami et al. 2023
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110866/pdf/fmicb-14-1097413.pdf
125. Trends in Allergic Conditions Among Children: United States, 1997–2011. Jackson et al. 2013.
https://www.cdc.gov/nchs/products/databriefs/db121.htm
126. Unyielding: Marathons Against Illegal Mandates. Thomas L. Rempfer, Philip G. Zimbardo. 2024. ISBN: 9781648210457
https://www.skyhorsepublishing.com/9781648210457/unyielding/
126 Appendix P. Memorandum from Contracting Officer at Fort Detrick. 3rd May 1999.
126 Appendix Q. Emails from Brigadier Eddie Cain. 3rd May 1999.
126 Appendix R. Memorandum: Reaffirmation of Military Requirement for Anthrax Vaccine Program. 18th August 2001.
126 Appendix S. Memorandum: Strategy Development for Force Health Protection Against Biological Threats. August 10th 2001.
126 Appendix U. Memorandum: Minutes of on Changing the Food and Drug Administration License for the Michigan Department of Public Health (MDPH) Anthrax Vaccine to Meet Military Requirement. 13th November 1995.
126 Appendix V. Food and Drug Administration Investigational New Drug Applications by MBPI and BioPort. 20th September 1996 and 1999.
127. DoD Directive: DoD Immunization Program for Biological Warfare Defense November 26th 1993.
https://apps.dtic.mil/sti/tr/pdf/ADA275188.pdf
128. Biological Threats and Terrorism: Assessing The Science and Response Capabilities: Workshop Summary: Vaccines: Research, Development, Production, and Procurement Issues 2002.
https://www.ncbi.nlm.nih.gov/books/NBK98400/
129. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military: Resources, Responsibilities, and Dynamics in the Military's Vaccine Mission.
https://www.ncbi.nlm.nih.gov/books/NBK220960/
130. Is Military Research Hazardous to Veteran’s Health? Lesson Spanning Half a Century. December 8th 1994.
https://apps.dtic.mil/sti/pdfs/ADA291587.pdf
131. United States General Accounting Office: Safety and Efficacy of the Anthrax Vaccine. Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division April 29th, 1999.
https://www.gao.gov/assets/t-nsiad-99-148.pdf
132. Dr. Kathryn C. Zoon Appointed to Emergent BioSolutions Board of Directors.
https://www.emergentbiosolutions.com/press/news-release-details-dr-kathryn-c-zoon-appointed-emergent-biosolutions-board/
133. Office of the Assistant Secretary of Defense (Public Affairs) Background Briefing. August 5th, 1999.
https://www.globalsecurity.org/space/library/news/1999/x08051999_x0805ant.htm
134. Canadian soldier wins anthrax case. May 5th, 2000.
https://www.upi.com/Archives/2000/05/05/Canadian-soldier-wins-anthrax-case/7921957499200/
135. H.R.2548 - To suspend further implementation of the Department of Defense anthrax vaccination program until the vaccine is determined to be safe and effective and to provide for a study by the National Institutes of Health of that vaccine. 106th Congress (1999-2000) Introduced 07/19/1999.
https://www.congress.gov/bill/106th-congress/house-bill/2548
136. Persian Gulf War Illnesses: Are We Treating Veterans Right? November 16th 1993.
https://ia801306.us.archive.org/26/items/persiangulfwaril00unit/persiangulfwaril00unit.pdf
137. U.S. ex rel. Dingle v. Bioport Corp Decision. 18th June 2003.
https://case-law.vlex.com/vid/u-s-ex-rel-892615320
138. United States General Accounting Office: Anthrax Vaccine, Changes to the Manufacturing Process. Statement of Nancy Kingsbury, Ph.D., Managing Director, Applied Research and Methods.
https://www.gao.gov/assets/gao-02-181t.pdf
139. September 11, 2001 : Attack on America. DoD News Briefing - Secretary Rumsfeld and Gen. Myers. October 18th, 2001.
https://avalon.law.yale.edu/sept11/dod_brief44.asp
140. Research Advisory Committee on Gulf War Veterans Illnesses Lesson Learned 12/16/2002.
https://www.va.gov/RAC-GWVI/docs/Committee_Documents/Letter_LessonsLearned_Dec2002.pdf
141. Anthrax Vaccine Adsorbed Package Inserts Revision: January 31, 2002.
https://www.ncbi.nlm.nih.gov/books/NBK220516/
142. Scientists Advise on Anthrax Vaccine Dec 20, 2001.
https://www.mrt.com/news/article/Scientists-Advise-on-Anthrax-Vaccine-7847651.php
143. CNN: Postal, Capitol Hill workers offered vaccine. December 20th, 2001.
https://www.cnn.com/2001/US/12/18/anthrax/
144. Department of Health and Human Services: Re: Docket No. OlP-0471/CPl 0J27J2002.
https://img1.wsimg.com/blobby/go/4fa7f468-a250-4088-926e-3c56a998df1f/downloads/FDA%20response%20to%20Citizen%20Petition_80027a9f.pdf?ver=1620969217312
145. §1107. Notice of use of an investigational new drug or a drug unapproved for its applied use.
https://www.govinfo.gov/content/pkg/USCODE-2020-title10/html/USCODE-2020-title10-subtitleA-partII-chap55-sec1107.htm
146. Senate Resolution 278: Expressing the Sense of the Senate Regarding the Anthrax and Small Pox Vaccines.
https://www.govinfo.gov/content/pkg/CREC-2003-11-25/html/CREC-2003-11-25-pt1-PgS16031-4.htm
147. Institute for Defense Analyses: Resuming Production of the Anthrax Vaccine as Quickly as Possible: Analysis of Alternative Business Arrangements.
https://apps.dtic.mil/sti/tr/pdf/ADA388211.pdf
148. Authorization of Emergency Use of Anthrax Vaccine Adsorbed for Prevention of Inhalation Anthrax by Individuals at Heightened Risk of Exposure Due to Attack With Anthrax; Availability A Notice by the Food and Drug Administration on 02/02/2005.
https://www.federalregister.gov/documents/2005/02/02/05-2028/authorization-of-emergency-use-of-anthrax-vaccine-adsorbed-for-prevention-of-inhalation-anthrax-by
149. The United States Department of Justice: Amerithrax Investigative Summary. February 19th , 2010.
https://www.justice.gov/archive/amerithrax/docs/amx-investigative-summary.pdf
150. Salon: The anthrax vaccine scandal.
https://www.salon.com/2001/10/15/anthrax_vaccine/
151. Transcript: Defense Department Briefing, October 12th, 2001.
https://www.globalsecurity.org/military//library/news/2001/10/mil-011012-usia05b.htm
152. Citizen’s Petition by Russel Dingle and Thomas Rempfer
https://img1.wsimg.com/blobby/go/4fa7f468-a250-4088-926e-3c56a998df1f/downloads/citizen%20petition%20ava%20rempfer%20dingle.pdf?ver=1620969217312
153. Vaccination and Neurodevelopmental Disorders: A Study of Nine-Year-Old Children Enrolled in Medicaid
Anthony R. Mawson et L. 2025
154. GAO: Anthrax Vaccine Safety and Efficacy Issues. Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division.
https://www.gao.gov/assets/t-nsiad-00-48.pdf
155. Vaccination and Neurodevelopmental Disorders: A Study of Nine-Year-Old Children Enrolled in Medicaid. Anthony R. Mawson1, Binu Jacob1.
https://ijvtpr.com/index.php/IJVTPR/article/view/100
156. Adverse Event Reporting: VAERS and WONDER Scott K. Winiecki, M.D. Center for Biologics Evaluation and Research U.S. Food and Drug Administration
https://www.fda.gov/media/93840/download
157. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Shimbukuro et al. 2015.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4632204/
158. Data Mining at FDA. Duggirala et al.
https://www.fda.gov/media/91848/download
159. Best Practices for FDA Staff in the Postmarketing Safety Surveillance of Human Drug and Biological Products.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER).
January 2024
https://www.fda.gov/media/130216/download
160. Blood Biomarkers of Chronic Inflammation in Gulf War Illness. Johnson et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4924830/
161. Gulf War Illness and Inflammation: Association of symptom severity with C-reactive protein. James et al. 2019.
https://www.jneurology.com/articles/gulf-war-illness-and-inflammation-association-of-symptom-severity-with-creactive-protein.html
162. Ocular and inflammatory markers associated with Gulf War illness symptoms. Kalahasty et al. 2023.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9981620/
163. Gulf War illness (GWI) as a neuroimmune disease. Georgopoulos et al. 2017.
https://pubmed.ncbi.nlm.nih.gov/28762055/
164. Lupus Anticoagulant in Gulf War Illness and Autoimmune Disorders: A Common Pathway Toward Autoimmunity. James et al. 2021.
https://www.immunologyresearchjournal.com/articles/lupus-anticoagulant-in-gulf-war-illness-and-autoimmune-disorders-a-common-pathway-toward-autoimmunity.html
165. Iraq and Afghanistan Veterans report symptoms consistent with chronic multisymptom illness one year after deployment. McAndrew et al. 2016.
https://pubmed.ncbi.nlm.nih.gov/27006173/
166. Reduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). Georgopoulos et al. 2015.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4739436/
167. Human Leukocyte Antigen (HLA) and Gulf War Illness (GWI): HLA-DRB1*13:02 Spares Subcortical Atrophy in Gulf War Veterans. James et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5832612/
168. Human Leukocyte Antigen (HLA) Alleles Prevent Metabolically-Induced Inflammation and Cerebrocortical Thinning in Gulf War Illness. Christover et al. 2020.
https://www.jneurology.com/articles/human-leukocyte-antigen-hla-alleles-prevent-metabolically-induced-inflammation-and-cerebrocortical-thinning-in-gulf-war-illness.html
169. Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection. Ascough et al. 2022.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9610610/
170. Cellular immune activation in Gulf War veterans. Skowera et al. 2004.
https://pubmed.ncbi.nlm.nih.gov/14997036/
171. Subcortical brain atrophy in Gulf War Illness. Christova et al. 2017.
https://pubmed.ncbi.nlm.nih.gov/28634886/
172. Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. Kang et al. 2000.
https://pubmed.ncbi.nlm.nih.gov/10824302/
173. Chronic Multisymptom Illness in Gulf War Veterans: Case Definitions Reexamined
Committee on the Development of a Consensus Case Definition for Chronic Multisymptom Illness in 1990-1991 Gulf War Veterans; Board on the Health of Select Populations; Institute of Medicine
https://pubmed.ncbi.nlm.nih.gov/25590117/
174. The Anthrax Vaccine Program: An Analysis of the CDC's Recommendations for Vaccine Use. Meryl Nass 1 2002.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1447151/
175. Gold hamsters vaccinated with 221 strains showed, absence of protection. STI-1 immunisation protected against the H-7 strain, but did not protect against the recombinant strain
https://pubmed.ncbi.nlm.nih.gov/25032373/
176. Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection. A P Pomerantsev. 1997
https://pubmed.ncbi.nlm.nih.gov/9413092/
177. Longitudinal health study of US 1991 Gulf War veterans: changes in health status at 10-year follow-up. Li et al. 2011.
https://pubmed.ncbi.nlm.nih.gov/21795757/
178. The Health of Gulf War and Gulf Era Veterans Over Time: U.S. Department of Veterans Affairs' Gulf War Longitudinal Study. Dursa et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/34483304/
179. Health Status of Female and Male Gulf War and Gulf Era Veterans: A Population-Based Study. Dursa et al. 2019.
https://pubmed.ncbi.nlm.nih.gov/31253241/
180. Health Status of Gulf War and Era Veterans Serving in the US Military in 2000. Porter et al. 2019.
https://pubmed.ncbi.nlm.nih.gov/29370011/
181. Physical and Mental Health Status of Gulf War and Gulf Era Veterans: Results From a Large Population-Based Epidemiological Study. Dursa et al. 2016.
https://pubmed.ncbi.nlm.nih.gov/26716848/
182. Health of US veterans of 1991 Gulf War: a follow-up survey in 10 years. Kang et al. 2009.
https://pubmed.ncbi.nlm.nih.gov/19322107/
183. Impaired immune function in Gulf War Illness. Whistler et al. 2009.
https://pubmed.ncbi.nlm.nih.gov/19265525/
184. Gulf War veterans' health: medical evaluation of a U.S. cohort. Eisen et l. 2005.
https://pubmed.ncbi.nlm.nih.gov/15941694/
185. Factor analysis of fatiguing syndrome in Gulf War era veterans: implications for etiology and pathogenesis. Young et al. 2003.
https://pubmed.ncbi.nlm.nih.gov/14665812/
186. Comparative Health Assessment Interview Research Study.
https://www.publichealth.va.gov/PUBLICHEALTH/epidemiology/studies/CHAI-study.asp
187. Lifetime Prevalence of Respiratory Diseases and Exposures Among Veterans of Operation Enduring Freedom and Operation Iraqi Freedom Veterans. Barth et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5482227/
188. Demographic, Military, and Health Characteristics of VA Health Care Users and Nonusers Who Served in or During Operation Enduring Freedom or Operation Iraqi Freedom, 2009-2011. Dursa et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5230837/
189. Chronic Multisymptom Illness Among Iraq/Afghanistan-Deployed US Veterans and Their Healthcare Utilization Within the Veterans Health Administration. Mohanty et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6109005/
190. Respiratory illness among Gulf War and Gulf War era veterans who use the Department of Veterans Affairs for healthcare. Dursa et al. 2020.
https://pubmed.ncbi.nlm.nih.gov/32851693/
191. Cerebral white matter structure is disrupted in Gulf War Veterans with chronic musculoskeletal pain. Riper et al. 2017.
https://pubmed.ncbi.nlm.nih.gov/28796115/
192. Pain among veterans of Operations Enduring Freedom and Iraqi Freedom. Gironda et al. 2006.
https://pubmed.ncbi.nlm.nih.gov/16898945/
193. Increased brain white matter axial diffusivity associated with fatigue, pain and hyperalgesia in Gulf War illness. Rayhan et al. 2013.
https://pubmed.ncbi.nlm.nih.gov/23526988/
194. Role of mitochondrial DNA damage and dysfunction in veterans with Gulf War Illness. Chen et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5599026/pdf/pone.0184832.pdf
195. Meta-analysis of self-reported health symptoms in 1990–1991 Gulf War and Gulf War-era veterans. Maule et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5829661/
196. Blood Biomarkers of Chronic Inflammation in Gulf War Illness. Johnson et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4924830/
197. Role of mitochondrial DNA damage and dysfunction in veterans with Gulf War Illness. Chen et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5599026/
198. Evidence for Somatic Hypersensitivity in Veterans with Gulf War Illness and Gastrointestinal Symptoms. Zhou et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6110965/
199. Gulf War illness in the Gulf War Era Cohort and Biorepository: The Kansas and Centers for Disease Control definitions. Gifford et al. 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10148241/
200. DTI-Derived Evaluation of Glymphatic System Function in Veterans with Chronic Multisymptom Illness. Zhang et al. 2026.
https://pubmed.ncbi.nlm.nih.gov/40579044/
201. Investigating the Eye as a Biomarker of Gulf War Illness: Sphingolipid and Eicosanoid Composition in Tears and Plasma. Jimenez et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12730409/
202. Immune transcriptomic changes in Australian Gulf War veterans. Fitch et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12674549/
203. Decadelong low basal ganglia NAA/tCr from elevated tCr supports ATP depletion from mitochondrial dysfunction and neuroinflammation in Gulf War illness. Cheshkov et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12634682/
204. Neurometabolite alterations in Gulf War Illness: a whole-brain magnetic resonance spectroscopy study. Jones et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12553559/
205. The U.S. Department of Veterans Affairs Gulf War Era Cohort Study: Results from the thirty-year follow-up assessment. Dursa et al. 2025.
https://pubmed.ncbi.nlm.nih.gov/41436390/
206. Upper gastrointestinal symptoms and Gulf War Illness in a clinical cohort of US veterans: a retrospective, cross-sectional study. Yousef et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12414160/
207. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. Fukuda et al. 1998.
https://pubmed.ncbi.nlm.nih.gov/9749480/
208. Longitudinal Patterns of Multimorbidity in Gulf War Era Veterans With and Without Gulf War Illness. Thomspo et al. 2025
https://pubmed.ncbi.nlm.nih.gov/38591766/
209. Longitudinal Assessment of Ocular Biomarkers in Individuals With Gulf War Illness Symptoms. Lai et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12208058/
210. Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia. Davis et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11931034/
211. Irritable Bowel Syndrome in Veterans With Gulf War Illness Evaluated at VA’s War-Related Illness and Injury Study Center. Djotsa et al. 2024.
https://academic.oup.com/milmed/article/189/11-12/e2644/7678875?login=true
212. Crisis in the gut: navigating gastrointestinal challenges in Gulf War Illness with bioengineering. Collier et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11229309/
213. Gulf war illness: a tale of two genomes. Coulomb et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11337741/
214. Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity. Coulomb et al. 2023.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10338554/
215. Gulf War Illness Is Associated with Host Gut Microbiome Dysbiosis and Is Linked to Altered Species Abundance in Veterans from the BBRAIN Cohort. Trivedi et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11354743/
216. Bioenergetic impairment in Gulf War illness assessed via 31P-MRS. Coulomb et al. 2014.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10979028/
217. Onset of Irritable Bowel Syndrome, Dyspepsia, Diarrhea, Bloating, and Constipation in Deployed Gulf War Veterans. Verne et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10935595/
218. Novel characterization of endogenous transient receptor potential melastatin 3 ion channels from Gulf War Illness participants. Gradisnik et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11198784/
219. Olfactory and cognitive decrements in 1991 Gulf War veterans with gulf war illness/chronic multisymptom illness. Chen 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10825982/
220. Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity. Colomb et al. 2023.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10338554/
221. Fatigue and Pain Severity in Gulf War Illness Is Associated With Changes in Inflammatory Cytokines and Positive Acute Phase Proteins. Hodgin et al. 2022.
https://pubmed.ncbi.nlm.nih.gov/35902364/
222. Dry eye symptoms and signs in US veterans with Gulf War Illness. Sanchex et al. 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9035031/
223. Gulf War illness in the Gulf War Era Cohort and Biorepository: The Kansas and Centers for Disease Control definitions. Gifford et al. 2023.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10148241/
224. Intestinal Hyperpermeability in Gulf War Veterans with Chronic Gastrointestinal Symptoms. Zhang et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6435429/
225. Exercise Challenge in Gulf War Illness Reveals Two Subgroups with Altered Brain Structure and Function. Rayhan et al. 2013.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3683000/
226. Exercise alters cerebellar and cortical activity related to working memory in phenotypes of Gulf War Illness. Washington et al. 2020.
227. Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. Khaiboullina et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4410698/
228. Metabolic features of Gulf War illness. Naivaux et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6660083/
229. Alterations in DNA Methylation Status Associated with Gulf War Illness. Trivedi et al. 2019.
https://pubmed.ncbi.nlm.nih.gov/30920300/
230. Insomnia Severity, Subjective Sleep Quality, and Risk for Obstructive Sleep Apnea in Veterans With Gulf War Illness. Chao et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5459361/
231. Mitochondrial Dysfunction in Gulf War Illness Revealed by 31Phosphorus Magnetic Resonance Spectroscopy: A Case-Control Study. Koslik et al. 2014.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3968048/
232. Role of mitochondrial DNA damage and dysfunction in veterans with Gulf War Illness. Chen et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5599026/
233. Neuropsychological characteristics of Gulf War illness: A meta-analysis. Janulewicz et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5435307/
234. Biological measures and diagnostic tools for Gulf War Illness - A systematic review. Gean et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/33741418/
235. Respiratory illness among Gulf War and Gulf War era veterans who use the Department of Veterans Affairs for healthcare. Dursa et al. 2020.
https://pubmed.ncbi.nlm.nih.gov/32851693/
236. Machine Learning Detects Pattern of Differences in Functional Magnetic Resonance Imaging (fMRI) Data between Chronic Fatigue Syndrome (CFS) and Gulf War Illness (GWI). Provenzano et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7407325/
237. Changes in Health Status in the Ft. Devens Gulf War Veterans Cohort: 1997-2017. Zundel et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7444112/
238. Physical and Mental Health Status of Gulf War and Gulf Era Veterans: Results From a Large Population-Based Epidemiological Study. Dursa et al. 2016.
https://pubmed.ncbi.nlm.nih.gov/26716848/
239. Prevalence of Chronic Multisymptom Illness/Gulf War Illness Over Time Among Millennium Cohort Participants, 2001 to 2016. Porter et al. 2020.
https://journals.lww.com/joem/fulltext/2020/01000/prevalence_of_chronic_multisymptom_illness_gulf.2.aspx
240. Gulf War Illness: Unifying Hypothesis for a Continuing Health Problem. Mawson et al. 2019.
241. Health of UK servicemen who served in Persian Gulf War. Unwin et al. 1999.
https://pubmed.ncbi.nlm.nih.gov/9923871/
242. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Steele. 2000.
https://pubmed.ncbi.nlm.nih.gov/11092441/
243. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. Hotopf et al. 2000.
pmc.ncbi.nlm.gov/articles/PMC27378/
244. Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure. Cherry et al. 2001.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1740138/
245. Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures. Kelsall et al. 2004.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1740679/
246. Reduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). Georgopoulos et al. 2015.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4739436/
247. Human Leukocyte Antigen (HLA) and Gulf War Illness (GWI): HLA-DRB1*13:02 Spares Subcortical Atrophy in Gulf War Veterans. James et al. 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5832612/
248. Adverse effects of Gulf War Illness (GWI) serum on neural cultures and their prevention by healthy serum. Georgopoulos et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6486178/
249. Human Immunoglobulin G (IgG) Neutralizes Adverse Effects of Gulf War Illness (GWI) Serum in Neural Cultures: Paving the Way to Immunotherapy for GWI. Tslibary et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6486180/
250. Anthrax Protective Antigen 63 (PA63): Toxic Effects in Neural Cultures and Role in Gulf War Illness (GWI). Tsilibary et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7328487/
251. Anthrax and Gulf War Illness (GWI): Evidence for the Presence of Harmful Anthrax Antigen PA63 In the Serum of Veterans with GWI. Tsilibary et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12311968/
252. A Magnetoencephalographic (MEG) Study of Gulf War Illness (GWI). Engdahl et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5078573/
253. Negative Association of Gulf War Illness Symptomatology with Predicted Binding Affinity of Anthrax Vaccine Antigen to Human Leukocyte (HLA) Class II Molecules. James et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11768865/
254. Anthrax Vaccination, Gulf War Illness, and Human Leukocyte Antigen (HLA). James et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11209475/
255. Anthrax Vaccines in the 21st Century. Georgopoulos et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10892718/
256. Gulf War illness (GWI) as a neuroimmune disease. Georgopoulos et al. 2017.
https://pubmed.ncbi.nlm.nih.gov/28762055/
257. Brain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). James et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5264269/
258. Brain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). James et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5264269/
259. Negative Association of Gulf War Illness Symptomatology with Predicted Binding Affinity of Anthrax Vaccine Antigen to Human Leukocyte (HLA) Class II Molecules. James et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11768865/
260. Anthrax Vaccination, Gulf War Illness, and Human Leukocyte Antigen (HLA). James et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11209475/
261. Brain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). James et al. 2016.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5264269/
262. Andrographolide Attenuates Gut-Brain-Axis Associated Pathology in Gulf War Illness by Modulating Bacteriome-Virome Associated Inflammation and Microglia-Neuron Proinflammatory Crosstalk. Saha et al. 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8304847/
263. Pain, But Not Physical Activity, Is Associated with Gray Matter Volume Differences in Gulf War Veterans with Chronic Pain. Ninnemanet al. 2022.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9295831/
264. Brainstem damage is associated with poorer sleep quality and increased pain in gulf war illness veterans. Zhang et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12088663/
265. Exploring brain mechanisms underlying Gulf War Illness with group ICA based analysis of fMRI resting state networks. Gonipath et al. 2019.
https://pubmed.ncbi.nlm.nih.gov/30825590/
266. Dynamic cerebral autoregulation is impaired in Veterans with Gulf War Illness: A case-control study. Falvo et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6188758/
267. In-vivo imaging of neuroinflammation in Veterans with Gulf War Illness. Alshelh et al. 2021.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7864588/
268. Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Haley et al. 2000.
https://pubmed.ncbi.nlm.nih.gov/10831703/
269. Hippocampal Dysfunction in Gulf War Veterans: Investigation with ASL Perfusion MR Imaging and Physostigmine Challenge. Li et al. 2011.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3176422/
270. Subcortical brain atrophy in Gulf War Illness. Cristova et al. 2017.
https://pubmed.ncbi.nlm.nih.gov/28634886/
271. Brainstem atrophy in Gulf War Illness. Zhang et al. 2020.
https://pubmed.ncbi.nlm.nih.gov/32081703/
272. Fatigue in Gulf War Illness is associated with tonically high activation in the executive control network. Wylie et al. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6411905/
273. Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness. Rayhal et al. 2013.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3603990/
274. Neuroimaging Markers for Studying Gulf-War Illness: Single-Subject Level Analytical Method Based on Machine Learning. Guan et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7699718/
275. The Prevalence of Mild Cognitive Impairment in a Convenience Sample of 202 Gulf War Veterans. Chao. 2020
https://pmc.ncbi.nlm.nih.gov/articles/PMC7579246/
276. Self-reported changes in subjective health and anthrax vaccination as reported by over 900 Persian Gulf War era veterans. Schumm et al. 2002.
https://pubmed.ncbi.nlm.nih.gov/12061608/
277. Depressed prostaglandins and leukotrienes in veterans with Gulf War illness. Golomb et al. 2019.
https://pubmed.ncbi.nlm.nih.gov/31033394/
278. Immunological dysfunction, vaccination and Gulf War illness. Peakman et al. 2006.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1569620/
279. Anthrax vaccination and self-reported symptoms, functional status, and medical conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Mahan et al. 2004.
https://pubmed.ncbi.nlm.nih.gov/15018879/
280. Vaccine-Induced Adverse Effects in Cultured Neuroblastoma 2A (N2A) Cells Duplicate Toxicity of Serum from Patients with Gulf War Illness (GWI) and Are Prevented in the Presence of Specific Anti-Vaccine Antibodies. Tsilibary et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7349801/
281. Longitudinal Patterns of Multimorbidity in Gulf War Era Veterans With and Without Gulf War Illness. Thompson et al. 2025.
https://pubmed.ncbi.nlm.nih.gov/38591766/
282. Small Fiber Neuropathy in Veterans With Gulf War Illness. Shadlack et al. 2024.
https://www.mdedge.com/fedprac/article/269038/neurology/small-fiber-neuropathy-veterans-gulf-war-illness
283. Risk factors for multisymptom illness in US Army veterans of the Gulf War. Wolfe et al. 2002.
https://pubmed.ncbi.nlm.nih.gov/11911029/
284. Brain Function in Gulf War Illness (GWI) and Associated Mental Health Comorbidities. Engdahl et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6417922/
285. A Neuroimmune Model of Gulf War Illness. Coughlin. 2018.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5976257/
286. Association of deployment characteristics and exposures with persistent ill health among 1990-1991 Gulf War veterans in the VA Million Veteran Program. Steele et al. 2024.
https://link.springer.com/article/10.1186/s12940-024-01118-7
287. Deployment-Related Toxic Exposures are Associated with Worsening Mental and Physical Health After Military Service: Results from a Self-Report Screening of Veterans Deployed After 9/11. Bourassa et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11102311/
288. Military Environmental Exposures. Miller. 2023.
https://pubmed.ncbi.nlm.nih.gov/37882403/
289. Evidence for abnormal cytokine expression in Gulf War Illness: A preliminary analysis of daily immune monitoring data. Parkitny et al. 2015.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4589096/
290. Gulf War Illness-associated increases in blood levels of interleukin 6 and C-reactive protein: biomarker evidence of inflammation. Butterick et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6921550/
291. Gulf war illness: a tale of two genomes. Golomb et al. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11337741/
292. Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness. Seth et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6832151/
293. Reactivation of Latent Herpesviruses and a Faulty Antiviral Response may Contribute to Chronic Multi-Symptom and Multi-System Illnesses in U.S. Military Veterans. Cox et al. 2025.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12090972/
294. Preliminary Evidence for the Role of Fungi, Specifically Chaetomium, in Gulf War Illness. Cherwonogrodsky et al. 2025.
https://pubmed.ncbi.nlm.nih.gov/38829681/
295. The Gut-Microbiome in Gulf War Veterans: A Preliminary Report. Janulewicz et al. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6801913/
296. Healthcare providers' perceived learning needs and barriers to providing care for chronic multisymptom illness and environmental exposure concerns. McAndrew et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/34425128/
297. "Because the country, it seems though, has turned their back on me": Experiences of institutional betrayal among veterans living with Gulf War Illness. Bloeser et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/34271400/
298. Grappling with Gulf War Illness: Perspectives of Gulf War Providers. Kaimal et al. 2020.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7699279/
299. Mycoplasmal infections in Fatigue and Autoimmune Illnesses: Chronic Fatigue Syndrome, Fibromyalgia Syndrome, Gulf War Illness and Rheumatoid Arthritis. Nicolson et al. 1998.
https://www.researchgate.net/publication/249886656_Mycoplasmal_infections_in_Fatigue_and_Autoimmune_Illnesses_Chronic_Fatigue_Syndrome_Fibromyalgia_Syndrome_Gulf_War_Illness_and_Rheumatoid_Arthritis
300. Gulf War Illnesses: Causes and Treatments. Nicolson 2001.
https://www.immed.org/GWI%20Research%20docs/06.26.12.updates.pdfs.gwi/GWI-GLNetal-AFMD.pdf
301. Signal detection and signal strengthening in CDC’s vaccine safety monitoring systems. Moro. 2015
https://health.mo.gov/living/wellness/immunizations/pdf/vaerscisa101515.pdf
302. Proportional Reporting Ratio. RxMD
https://www.rxmd.com/proportional-reporting-ratio/
303. Data Mining at FDA -- White Paper. 2018.
https://www.fda.gov/science-research/data-mining/data-mining-fda-white-paper
304. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 21: Surveillance for Adverse Events Following Immunization Using the Vaccine Adverse Event Reporting System (VAERS). Feb 22 2024.
https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-21-vaers.html
305. Vaccine Safety Systems: About the Clinical Immunization Safety Assessment (CISA) Project. May 12, 2025.
https://www.cdc.gov/vaccine-safety-systems/hcp/cisa/
306. Vaccine Safety Systems: Accessing and Using Data from the Vaccine Safety Datalink (VSD). November 25, 2024.
https://www.cdc.gov/vaccine-safety-systems/vsd/access-use.html
307. British Medical Journal: Is the US’s Vaccine Adverse Event Reporting System broken? 2023.
https://www.bmj.com/content/383/bmj.p2582
308. FDA Adverse Event Monitoring System (AEMS)
https://www.fda.gov/safety/fda-adverse-event-monitoring-system-aems
309. Nature: The FAIR Guiding Principles for scientific data management and stewardship.
https://www.nature.com/articles/sdata201618
310. https://www.hhs.gov/maha/index.html
311. https://www.themahareport.com/
312. https://www.mahainstitute.us/
313. Time: Big Pharma is Highjacking the Information that Doctors Need Most. Abramson. 2022.
https://time.com/6171999/big-pharma-clinical-data-doctors/
314. Universities in the Marketplace: The Commercialization of Higher Education. Bok. 2004.
https://press.princeton.edu/books/paperback/9780691120126/universities-in-the-marketplace
315. The contract research organization and the commercialization of scientific research. Mirowski et al. 2005.
https://pubmed.ncbi.nlm.nih.gov/16304738/
316. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Lexchin et al. 2003.
https://pmc.ncbi.nlm.nih.gov/articles/PMC156458/
317. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. Bekelman et al. 2003.
https://pubmed.ncbi.nlm.nih.gov/12533125/
318. Big Pharma – How Much Power Do Drug Companies Have? Jabari. 2025.
https://16thcouncil.uk/big-pharma-how-much-power-do-drug-companies-have/